24353

    211745

    NEPHROCARE

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    NEPHRO CARE INDIA LIMITED Share Price Today

    NEPHRO CARE INDIA LIMITED is currently trading at ₹62.85, up by ₹0.0 from the previous close. The stock touched an intraday high of ₹62.85 and a low of ₹62.85 during the latest trading session. Over the past one year, NEPHRO CARE INDIA LIMITED has delivered a loss of 55.55%, while the stock has declined 2.17% in the last one month.

    NEPHRO CARE INDIA LIMITED performance

    Today’s low Today’s high
    ₹ 62.85 ₹ 62.85
    ₹ 62.85
    52 week low 52 week high
    ₹ 50.05 ₹ 183.00
    ₹ 62.85
    Open Price ₹ 62.85
    Prev. Close ₹ 62.85
    Volume (Shares) 4400.00
    Total traded value ₹ 2.76
    Upper Circuit ₹ 65.95
    Lower Circuit ₹ 59.75
    info

    Investment Returns

    Over 1 Month -2.17% Over 3 Months -28.95% Over 6 Months -35.76% Over 1 Year -55.55%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    NEPHRO CARE INDIA LIMITED fundamentals


    • Market cap (Cr) 103.60
    • P/E Ratio (TTM) 30.81
    • Beta 1.29
    • Book Value / share 34.48
    • Return on equity 8.38%
    • EPS (TTM) 2.04
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 1.00
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    NEPHRO CARE INDIA LIMITED Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 26.75
    Operating Expense 26.27
    Net Profit 1.00
    Net Profit Margin (%) 3.73
    Earnings Per Share (EPS) 0.61
    EBITDA 2.85
    Effective Tax Rate (%) 22.30
    Particulars DEC 2025 (Values in Cr)
    Revenue 22.66
    Operating Expense 22.18
    Net Profit 0.42
    Net Profit Margin (%) 1.85
    Earnings Per Share (EPS) 0.26
    EBITDA 1.99
    Effective Tax Rate (%) 25.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 7.48
    Operating Expense 0.00
    Net Profit 1.01
    Net Profit Margin (%) 13.50
    Earnings Per Share (EPS) 0.85
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars DEC 2023 (Values in Cr)
    Revenue 6.65
    Operating Expense 0.00
    Net Profit -0.25
    Net Profit Margin (%) -3.75
    Earnings Per Share (EPS) 0.00
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 88.73
    Operating Expense 85.64
    Net Profit 3.37
    Net Profit Margin (%) 3.79
    Earnings Per Share (EPS) 2.04
    EBITDA 9.87
    Effective Tax Rate (%) 27.37
    Particulars MAR 2025 (Values in Cr)
    Revenue 46.03
    Operating Expense 42.73
    Net Profit 3.64
    Net Profit Margin (%) 7.90
    Earnings Per Share (EPS) 2.38
    EBITDA 7.40
    Effective Tax Rate (%) 24.63
    Particulars MAR 2024 (Values in Cr)
    Revenue 27.23
    Operating Expense 21.38
    Net Profit 4.41
    Net Profit Margin (%) 16.19
    Earnings Per Share (EPS) 3.80
    EBITDA 6.84
    Effective Tax Rate (%) 27.65
    Particulars MAR 2023 (Values in Cr)
    Revenue 17.09
    Operating Expense 14.52
    Net Profit 2.37
    Net Profit Margin (%) 13.86
    Earnings Per Share (EPS) 38.85
    EBITDA 3.42
    Effective Tax Rate (%) 7.75
    Particulars MAR 2022 (Values in Cr)
    Revenue 3.42
    Operating Expense 3.43
    Net Profit -0.01
    Net Profit Margin (%) -0.29
    Earnings Per Share (EPS) -0.20
    EBITDA 0.13
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 32.44
    ROE % 8.38
    ROCE % 11.18
    Total Debt to Total Equity 0.00
    EBITDA Margin 13.70
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 12.62
    ROE % 50.26
    ROCE % 61.86
    Total Debt to Total Equity 0.14
    EBITDA Margin 24.47
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 50.57
    ROE % 156.44
    ROCE % 65.51
    Total Debt to Total Equity 1.65
    EBITDA Margin 18.84
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 9.90
    ROE % -153.85
    ROCE % 1.59
    Total Debt to Total Equity 6.22
    EBITDA Margin 4.09
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 15.00
    ROE % 450.00
    ROCE % 20.83
    Total Debt to Total Equity 34.57
    EBITDA Margin 8.79
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4.65
    Total Assets 68.28
    Total Liabilities 68.28
    Total Equity 53.48
    Share Outstanding 1
    Price to Book Ratio 3.92
    Return on Assets (%) 5.32
    Return on Capital (%) 6.8
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.29
    Total Assets 20.96
    Total Liabilities 20.96
    Total Equity 15.02
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 21.03
    Return on Capital (%) 29.36
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2.31
    Total Assets 8.25
    Total Liabilities 8.25
    Total Equity 2.52
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 28.72
    Return on Capital (%) 47.35
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.60
    Total Assets 4.62
    Total Liabilities 4.62
    Total Equity 0.49
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -0.21
    Return on Capital (%) -0.32
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.48
    Total Assets 1.28
    Total Liabilities 1.28
    Total Equity 0.21
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 10.53
    Return on Capital (%) 14.85
    Particulars MAR 2025 (Values in Cr)
    Net Income 4.82
    Cash from Operations 9.06
    Cash from Investing -39.55
    Cash from Financing 35.10
    Net change in Cash 3.36
    Free Cash Flow 38.27
    Particulars MAR 2024 (Values in Cr)
    Net Income 6.22
    Cash from Operations 3.20
    Cash from Investing -7.53
    Cash from Financing 5.60
    Net change in Cash -1.02
    Free Cash Flow 5.63
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.57
    Cash from Operations 4.16
    Cash from Investing -2.33
    Cash from Financing -0.08
    Net change in Cash 1.70
    Free Cash Flow 4.66
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.00
    Cash from Operations 0.68
    Cash from Investing -2.81
    Cash from Financing 2.32
    Net change in Cash 0.12
    Free Cash Flow 2.13
    Particulars MAR 2021 (Values in Cr)
    Net Income 0.11
    Cash from Operations 0.19
    Cash from Investing -0.06
    Cash from Financing 0.27
    Net change in Cash 0.44
    Free Cash Flow 0.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8931.65 65.65 13.55 128423.42 6680.00 9008.90
    FORTIS MALAR HOSPITALS LIMITED 50.02 22.63 2.73 93.75 40.75 76.00
    SHREE PACETRONIX LTD. 137.05 16.35 2.88 51.39 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.02 0.00 2.73 22.88 1.83 5.17
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8931.65 85.54 12.88 128423.42 6680.00 9008.90
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 37.85 0.00 -9.20 28.27 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5940.30 26.58 4.92 6498.69 5010.00 6725.00

    NEPHRO CARE INDIA LIMITED shareholding pattern

    Holding
    36.03%
    61.71%
    0.96%
    1.29%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    NEPHRO CARE INDIA LIMITED Technicals Summary

    62.85 0.00 redarrow
    red-green-graph indicator
    15 Bearish
    1 Bullish
    • 5 Days 63.00
    • 26 Days 66.10
    • 10 Days 63.80
    • 50 Days 69.20
    • 12 Days 64.20
    • 100 Days 76.10
    • 20 Days 65.30
    • 200 Days 93.70
    62.15 PIVOT
    First Support 61.30 First Resistance 63.80 Second Support 59.65 Second Resistance 64.65 Third Support 58.80 Third Resistance 66.30
    RSI 37.40 ADX 37.85 MACD -2.02 Williams % R -78.55 Commodity Channel Index (CCI) -108.39
    Date 2026-07-29 Week 11533.00 Same Day 13600.00 Month 11270.00
    1 Year 1.30 3 Year 1.27
    Over 1 Month
    -2.17% down
    Over 1 Year
    -55.55% down
    Over 3 Months
    -28.95% down
    Over 3 Years
    -29.48% down
    Over 6 Months
    -35.76% down
    Over 5 Years
    0.00% down

    NEPHRO CARE INDIA LIMITED Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Nephro Care India Ltd?

    Answer Field

    Nephro Care India Ltd share price is for NSE ₹ 62.85 & for BSE ₹ 0.00 as on Jul 31 2026 10:02 AM.

    What is the Market Cap of Nephro Care India Ltd Share?

    Answer Field

    The market cap of Nephro Care India Ltd for NSE ₹ 103.60 & for BSE ₹ 0.00 as on Jul 31 2026 10:02 AM.

    What is the 52 Week High and Low of Nephro Care India Ltd?

    Answer Field

    The 52 Week High and Low of Nephro Care India Ltd for NSE is ₹ 183.00 and ₹ 50.05 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Nephro Care India Ltd?

    Answer Field

    The 1 year returns on the stock has been -56.80%.

    What is the P/E Ratio of Nephro Care India Ltd Share?

    Answer Field

    As on Jul 31 2026 10:02 AM the price-to-earnings (PE) ratio for Nephro Care India Ltd share is 30.81.

    What is the PB ratio of Nephro Care India Ltd Share?

    Answer Field

    As on Jul 31 2026 10:02 AM, the price-to-book (PB) ratio for Nephro Care India Ltd share is 34.48.

    How to Buy Nephro Care India Ltd Share?

    Answer Field

    You can trade in Nephro Care India Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Nephro Care India Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Nephro Care India Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Nephro Care India Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |